U.S. pharma giant copyright scrapped two experimental weight loss supplements past yr—a after-each day capsule, lotiglipron, due to elevated liver enzymes plus a two times-each day capsule, danuglipron, on account of robust Unintended effects—but CEO Albert Bourla has claimed the company is determined to “Enjoy and earn” within the weight p